BioCryst Pharmaceuticals | Aktywa



Current Assets Zmiana Data
Alnylam Pharmaceuticals USD 3.27B 27.03M 2025-03
Chugai Pharma JPY 1.52T 89.64B 2025-03
Daiichi Sankyo JPY 1.91T 66.22B 2025-03
DBV Technologies USD 29.15M 15.24M 2025-03
Gilead Sciences USD 19.17B 4.39B 2024-12
GlaxoSmithKline GBP 18.08B 1.09B 2025-03
Glaxosmithkline GBP 17B 301M 2024-12
Incyte USD 3.23B 7.24M 2025-03
Ionis Pharmaceuticals USD 2.42B 201.36M 2025-03
Neurocrine Biosciences USD 1.72B 151.9M 2024-12
PTC Therapeutics USD 2.32B 950.88M 2025-03
Regeneron Pharmaceuticals USD 17.57B 9.64B 2025-03
Roche Holding CHF 40.04B 6.41B 2024-12
Sarepta Therapeutics USD 2.43B 640.93M 2025-03
Ultragenyx Pharmaceutical USD 817.12M 17.52M 2024-12
Vertex Pharmaceuticals USD 9.6B 207.7M 2024-12



BioCryst Pharmaceuticals Aktywa - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Jul 2025.